All

Meet ASPIRE: Galderma Rolls Out New Customer Loyalty Program

Galderma is rolling out a new loyalty program for both doctors and patients.

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.

All

How VYC-12L Performs in Treating Horizontal Neck Lines

A principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.

AAD Issues Strong Recommendations for Four Therapies in Updated Atopic Dermatitis Guidelines

by Alyx Arnett | Jul 11, 2025 | Eczema | 0

The American Academy of Dermatology issued four strong evidence-based recommendations for the treatment of atopic dermatitis in adults in its 2025 focused update.

Galderma Launches ‘Scratch Resistance’ Campaign for Atopic Dermatitis Treatment

by Alyx Arnett | Apr 23, 2025 | Eczema | 0

The broadcast and digital campaign aims to spotlight the emotional burden of eczema-related itch and promote Galderma’s Nemluvio.

Galderma Launches Updated Alastin Restorative Skin Complex with New Ingredients

by Alyx Arnett | Apr 18, 2025 | Cosmetics & Skin Care | 0

Alastin’s enhanced serum includes a proprietary peptide and novel fat-stimulating ingredient for collagen and volume support.

Galderma Restylane Eyelight HA Filler Receives FDA Approval

by Alison Werner | Jun 5, 2023 | Anti-Aging, Injectibles | 0

Restylane Eyelight, an undereye hyaluronic acid (HA) dermal filler, is formulated with NASHA Technology for volume loss under the eyes.

Galderma Sponsors SCOPE Miami Beach 2022

by Steven Martinez | Nov 28, 2022 | Injectibles | 0

Galderma is sponsoring the SCOPE Miami Beach 2022 showcase for contemporary art, offering consultations and real-time treatments to visitors.

Galderma, NBCF to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors

by Keri Stephens | Oct 3, 2022 | Breast Cancer, Company News | 0

Galderma is featuring the personal stories and treatment journeys of breast cancer survivors who received Galderma’s aesthetic portfolio of products in a campaign on their social channels during Breast Cancer Awareness Month in October.

Galderma Phase 3 Trial Shows Wrinkle Reducing Results

by Steven Martinez | Jun 13, 2022 | Botox, Injectibles | 0

Galderma’s wrinkle treatment, RelabotulinumtoxinA, reduced wrinkles with minimal side effects in two phase III clinical studies.

Galderma to Present New Clinical Data On Portfolio of Products

by Steven Martinez | Mar 30, 2022 | Anti-Aging | 0

Galderma will share a host of clinical and patient satisfaction data on its portfolio of products at the AMWC in Monaco.

Galderma Launches Alastin Skincare ReFORM & RePAIR COMPLEX with TriHex Technology

by Alison Werner | Feb 14, 2022 | Cosmetics & Skin Care | 0

The newest product in the Alastin Skincare line, it’s designed to assist with recovery from aesthetic surgical body procedures.

Galderma Successfully Completes Acquisition of ALASTIN Skincare

by Debbie Overman | Jan 5, 2022 | Company News, Cosmetics & Skin Care | 0

Galderma announces that it has received antitrust clearance from the US authorities and has completed the acquisition of ALASTIN Skincare Inc.

Galderma Receives FDA Approval for New SCULPTRA Label, Offering More Options to Aesthetic Partners

by Debbie Overman | Dec 13, 2021 | Injectibles | 0

Galderma announces the new label for SCULPTRA (injectable poly-L-lactic acid (PLLA)), the first and only FDA-approved PLLA facial injectable treatment that helps stimulate the skin’s own collagen production, to smooth facial wrinkles, such as smile lines.

Tag: Galderma

All

All

All